REQUEST A DEMO
Total
USD $0.00
Search more companies

Viologika-Pharma Sas (Colombia)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Viologika-Pharma Sas Profile Updated: January 26, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English & Spanish Download a sample report

Viologika-Pharma Sas is a company in Colombia, with a head office in Bogota D.C.. It operates in the Drugs and Druggists' Sundries Merchant Wholesalers industry. It was established on August 29, 2018. 19 (2023) employees currently work for Viologika-Pharma Sas. From the latest financial highlights, Viologika-Pharma Sas reported a net sales revenue increase of 115.32% in 2022. Its’ total assets recorded a growth of 89.06%. The net profit margin of Viologika-Pharma Sas increased by 1.86% in 2022.

Headquarters
Calle 23 # 116 - 31 Bg 11
Bogota D.C.; Bogota D.C; Postal Code: 0704

Contact Details: Purchase the Viologika-Pharma Sas report to view the information.

Basic Information
Total Employees:
Purchase the Viologika-Pharma Sas report to view the information.
Outstanding Shares:
Purchase the Viologika-Pharma Sas report to view the information.
Incorporation Date:
August 29, 2018
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Alternate Legal Representative
Purchase this report to view the information.
Fiscal Inspector
Company Performance
Financial values in the chart are available after Viologika-Pharma Sas report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
115.32%
Total operating revenue
115.32%
Operating profit (EBIT)
18.62%
Net Profit (Loss) for the Period
280.32%
Total assets
89.06%
Total equity
119.17%
Operating Profit Margin (ROS)
-1.88%
Net Profit Margin
1.86%
Return on Equity (ROE)
24.02%
Quick Ratio
0.22%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?